Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis

Εμφάνιση άλλων εκδόσεων (1)

The efficacy of Bacillus Calmette-Guerin (BCG) vaccination in protection against pulmonary tuberculosis (TB) is highly variable between populations. One possible explanation for this variability is increased exposure of certain populations to non-tuberculous mycobacteria (NTM). This study used a mur...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Poyntz, H, Stylianou, E, Griffiths, K, Marsay, L, Checkley, A, McShane, H
Μορφή:	Journal article
Έκδοση:	2014

Παρόμοια τεκμήρια

Non-tuberculous mycobacteria have diverse effects on BCG efficacy against Mycobacterium tuberculosis.
ανά: Poyntz, H, κ.ά.
Έκδοση: (2014)

Measuring exposure to non-tuberculous mycobacteria: defining and testing novel antigens
ανά: Checkley, A, κ.ά.
Έκδοση: (2012)

Evaluation of immunological mechanisms induced by Mycobacterium avium exposure and the effect upon pre-existing BCG immunity
ανά: Poyntz, H, κ.ά.
Έκδοση: (2011)

Identification of antigens specific to non-tuberculous mycobacteria: the Mce family of proteins as a target of T cell immune responses.
ανά: Checkley, A, κ.ά.
Έκδοση: (2011)

Cholera toxin enhances vaccine-induced protection against Mycobacterium tuberculosis challenge in mice
ανά: Griffiths, K, κ.ά.
Έκδοση: (2013)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb)
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Th1/Th17 cell induction following vaccination with the novel tuberculosis vaccine MVA85A and their role in Mycobacterium tuberculosis challenge
ανά: Griffiths, K, κ.ά.
Έκδοση: (2011)

Tuberculosis vaccines: Progress and challenges
ανά: Checkley, A, κ.ά.
Έκδοση: (2011)

Mycobacterial growth inhibition in murine splenocytes as a surrogate for protection against Mycobacterium tuberculosis (M. tb).
ανά: Marsay, L, κ.ά.
Έκδοση: (2013)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
ανά: Poyntz, HC
Έκδοση: (2012)

Boosting with poxviruses enhances Mycobacterium bovis BCG efficacy against tuberculosis in guinea pigs.
ανά: Williams, A, κ.ά.
Έκδοση: (2005)

Improvement of BCG protective efficacy with a novel chimpanzee adenovirus and a modified vaccinia Ankara virus both expressing Ag85A
ανά: Stylianou, E, κ.ά.
Έκδοση: (2015)

The tuberculin skin test (TST) is affected by recent BCG vaccination but not by exposure to non-tuberculosis mycobacteria (NTM) during early life.
ανά: Burl, S, κ.ά.
Έκδοση: (2010)

Tuberculosis vaccines: progress and challenges.
ανά: Checkley, A, κ.ά.
Έκδοση: (2011)

Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy.
ανά: Minassian, A, κ.ά.
Έκδοση: (2011)

Inflammation and immune activation are associated with risk of Mycobacterium tuberculosis infection in BCG-vaccinated infants
ανά: Satti, I, κ.ά.
Έκδοση: (2022)

Diagnostic accuracy of intracellular mycobacterium tuberculosis detection for tuberculous meningitis.
ανά: Feng, G, κ.ά.
Έκδοση: (2014)

Assessing the immunogenic and protective potential of different viral vector regimes, in the mouse model of tuberculosis infection
ανά: Stylianou, E, κ.ά.
Έκδοση: (2011)

Vaccination against tuberculosis: how can we better BCG?
ανά: Pitt, J, κ.ά.
Έκδοση: (2013)

Vaccination against tuberculosis: How can we better BCG?
ανά: Pitt, J, κ.ά.
Έκδοση: (2013)

Viral booster vaccines improve Mycobacterium bovis BCG-induced protection against bovine tuberculosis.
ανά: Vordermeier, H, κ.ά.
Έκδοση: (2009)

The frequency of non tuberculosis mycobacteria among isoniazid resistant Mycobacterium isolates and the pattern of resistance to antituberculosisdrugs
ανά: Perpustakaan UGM, i-lib
Έκδοση: (2010)

Randomised controlled trial of single BCG, repeated BCG, or combined BCG and killed Mycobacterium leprae vaccine for prevention of leprosy and tuberculosis in Malawi
ανά: Fine, P, κ.ά.
Έκδοση: (1996)

Proteoliposomes from mycobacterium bovis BCG and mycobacterium smegmatis as new vaccine candidates against tuberculosis
ανά: Kadir, Ramlah
Έκδοση: (2016)

Erratum: Viral booster vaccines improve mycobacterium bovis BCG-induced protection against bovine tuberculosis
ανά: Vordermeier, H, κ.ά.
Έκδοση: (2011)

Revaccination with BCG: does it work?
ανά: McShane, H
Έκδοση: (2024)

Understanding BCG is the key to improving it.
ανά: McShane, H
Έκδοση: (2013)

Immunoproteomic Analysis Of Mycobacterium Tuberculosis And Nontuberculous Mycobacteria Towards The Discovery Of Potential Universal Or Species Specific Biomarkers
ανά: Razman, Aimi Zafira
Έκδοση: (2017)

Safety of a controlled human infection model of tuberculosis with aerosolised, live-attenuated Mycobacterium bovis BCG versus intradermal BCG in BCG-naive adults in the UK: a dose-escalation, randomised, controlled, phase 1 trial
ανά: Satti, I, κ.ά.
Έκδοση: (2024)

Why don’t we have an effective tuberculosis vaccine yet?
ανά: Davenne, T, κ.ά.
Έκδοση: (2016)

Mycobacterium tuberculosis PPD-induced immune biomarkers measurable in vitro following BCG vaccination of UK adolescents by multiplex bead array and intracellular cytokine staining
ανά: Smith, S, κ.ά.
Έκδοση: (2010)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate tuberculosis vaccine, MVA85A, alone and in combination.
ανά: Harris, SA, κ.ά.
Έκδοση: (2014)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG.
ανά: Tameris, M, κ.ά.
Έκδοση: (2013)

Lessons learnt from the first efficacy trial of a new infant tuberculosis vaccine since BCG
ανά: Tameris, M, κ.ά.
Έκδοση: (2013)

Editorial commentary: Understanding BCG is the key to improving it
ανά: McShane, H
Έκδοση: (2014)

Profiling non-tuberculous mycobacteria in an Asian setting : characteristics and clinical outcomes of hospitalized patients in Singapore
ανά: Chotirmall, Sanjay Haresh, κ.ά.
Έκδοση: (2018)

Immunogenicity and protective efficacy of prime-boost regimens with recombinant (delta)ureC hly+ Mycobacterium bovis BCG and modified vaccinia virus ankara expressing M. tuberculosis antigen 85A against murine tuberculosis.
ανά: Tchilian, E, κ.ά.
Έκδοση: (2009)

Influence of antituberculosis drug resistance and Mycobacterium tuberculosis lineage on outcome in HIV-associated tuberculous meningitis.
ανά: Tho, D, κ.ά.
Έκδοση: (2012)

The SIGLEC14 null allele is associated with Mycobacterium tuberculosis- and BCG-induced clinical and immunologic outcomes
ανά: Graustein, A, κ.ά.
Έκδοση: (2017)

Erratum: Immunogenicity and protective efficacy of prime-boost regimens with recombinant δureC hly+ Mycobacterium bovis BCG and modified Vaccinia virus Ankara expressing M. tuberculosis antigen 85A against murine tuberculosis
ανά: Tchilian, E, κ.ά.
Έκδοση: (2011)